healthcare
Indian optician raises $6.4m from AHF, Ventureast
Asia Healthcare Fund (AHF) and early-stage player Ventureast have together invested INR400 million in Eye Gear Optics India, the start-up behind optical retail chain Ben Franklin.
AIF sells India's Famy Care to US-listed Myland for $750m
AIF Capital has sold its stake in Famy Care, an Indian maker of female oral contraceptives, to US-based pharmaceutical firm Mylan Laboratories for $750 million plus contingent payments of up to $50 million.
CICC funds exit China TCM business as rival agrees $1.3b buyout
Two PE funds managed by China International Capital Corporation (CICC) will exit Jiangyin Tianjiang Pharmaceutical as China Traditional Chinese Medicine (China TCM) buys a majority stake in the business for up to RMB8.34 billion ($1.34 billion).
Quadria seals landmark Indonesia pharma deal
Southeast Asia-focused healthcare investor Quadria Capital, which is expected to close its latest fund in the next two months, has taken a minority stake in Indonesian drug manufacturer Soho Global Health.
Legend Capital leads $100m round for China’s Innovent Biologics
Legend Capital has led a Series C round of funding worth $100 million for Innovent Biologics, a Chinese biopharmaceutical company.
Japan's Mitsui Global backs clinical SaaS start-up
Japan’s Mitsui Global Investment and Dolby Family Ventures have together invested $12 million in cloud-based, clinical study software start-up goBalto.
Carlyle-backed Meinian Onehealth invests in rival Ciming Health
Meinian Onehealth Healthcare, China’s largest private provider of healthcare check-up services and a portfolio company of The Carlyle Group, has invested in industry rival Ciming Health Checkup Management Group.
Temasek acquires 18% stake in Indian hospital operator
Temasek Holdings - an investment arm of the Singapore government - has acquired a 17.74% stake in Global Health, which operates the Mendanta super specialty hospital in Gurgaon, India.
Australian medical research fund backs antibody start-up
Solvanix, an Australian early-stage biotech company that has developed a technology for improving drug stability, has received A$2 million ($1.6 million) in seed funding from the Medical Research Commercialization Fund (MRCF).
CDC commits $48m to India healthcare provider
UK development finance institution (DFI) CDC Group has invested $48 million in Indian multi-specialty healthcare provider Narayana Hrudayalaya Hospitals (NH) in return for a small minority stake.
Yunfeng joins $1.6b deal for China drug maker Baiyunshan
Yunfeng Capital and other investors have agreed to invest up to RMB10 billion ($1.6 billion) in Chinese drug maker Guangzhou Baiyushan Pharmaceutical Holdings.
China's BVCF provides $8m round for US biotech firm
China-focused biotech investor BVCF has led an $8 million Series A round of funding for DiaCarta, a US-based firm that develops test kits for detecting cancer.
Ally Bridge leads $25m round for Shanghai Hua Medicine
Ally Bridge Group, a healthcare-focused PE firm, has led a $25 million Series B round of funding for Hua Medicine, a Shanghai-based clinical-stage biotech company.
Xeraya, Spruce in $150m first close on second life sciences fund
Khazanah Nasional-controlled Xeraya Capital and Spruce Capital Partners have reached a first close of $150 million on MLS Capital Fund II, successor to the vintage Malaysian Life Sciences Capital Fund, which is now fully allocated.
MSPEA enters the China hospital space
To Homer Sun, CIO at Morgan Stanley Private Equity Asia (MSPEA), the current climate in China’s hospital services space is reminiscent of pharmaceuticals circa 2008. Government policy was pushing the industry towards consolidation and MSPEA capitalized,...
Australian cancer drug developer raises $10m Series B round
Australian biopharmaceutical start-up EnGeneIC has received $10 million in a Series B round of funding led by Boston-based healthcare specialist GRT Capital Partners.
Chinese insurers win approval for SME-focused PE funds
Chinese insurance companies have been permitted to set up private equity funds that specifically focus on investing in local small and medium-sized enterprises (SMEs).
MSPEA, Sihuan Pharma invest in Chinese hospitals - UPDATE
Morgan Stanley Private Equity Asia (MSPEA) has teamed up with Sihuan Pharmaceuticals – one of its portfolio companies – and that company’s chairman to invest RMB1.24 billion ($200 million) in two Chinese hospitals.
Hony, Goldman lead investment in Neusoft medical device units
A consortium including Hony Capital, Goldman Sachs and Canada Pension Plan Investment Board (CPPIB) has agreed to invest $610 million in two medical device subsidiaries owned by Neusoft Corporation, a Chinese IT services provider.
Fidelity backs China-based antibody specialist
Two Fidelity funds have participated in a Series A round of funding worth $8 million for Adagene, a China-based life sciences company that specializes in smart antibody technology.
Japan PE acquires plastics manufacturer, elderly care business
Mid-market GP Japan Private Equity has acquired plastics manufacturer Sekisui Chemicals and care home services business Healthy Service via its third buyout fund.
Taiwan’s CDFH, Fujian Electronics in first close on debut RMB fund
Taiwan-based China Development Financial Holding (CDFH) and China’s Fujian Electronics & Information Group have reached a first close of RMB1 billion ($162 million) on their debut renminbi-denominated fund.
Qiming leads $10m round for China biopharma player
Qiming Venture Partners has led a $10 million Series A round of funding for CANbridge Life Science, a Beijing-based biopharmaceutical firm.
China healthcare: Technology transfer
Healthcare-focused private equity firms want to take technologies from developed markets into China, leveraging rising domestic demand. It is a lucrative strategy, but not necessarily a straightforward one